New Anti-inflammatory Treatment Strategy in Alzheimer’s Disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (107)
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
1999 • 3,112 citations
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease
1996 • 1,371 citations
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
1991 • 1,290 citations
Clinical trial of indomethacin in Alzheimer's disease
1993 • 996 citations
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
1997 • 990 citations
Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage
1997 • 728 citations
Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression
1998 • 695 citations
Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
1997 • 601 citations
Microglia in degenerative neurological disease
1993 • 594 citations
Microglial response to amyloid plaques in APPsw transgenic mice.
1998 • 580 citations
Inverse association of anti‐inflammatory treatments and Alzheimer's disease
1994 • 567 citations
Elevated circulating tumor necrosis factor levels in Alzheimer's disease
1991 • 489 citations
The enzymatic formation of prostaglandin E2 from arachidonic acid prostaglandins and related factors 32
1964 • 473 citations
Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs
1995 • 460 citations
Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
1998 • 455 citations
Brain macrophages: evaluation of microglia and their functions
1992 • 443 citations
Nonsteroidal anti-inflammatory drugs in Alzheimer's disease
1995 • 442 citations
Amyloid-β peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease
1997 • 416 citations
Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.
1992 • 362 citations
Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism
1998 • 339 citations
Activation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils
1997 • 321 citations
Amyloid-β peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release
1998 • 313 citations
Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?
1995 • 284 citations
Mechanism of action of antiinflammatory drugs.
1998 • 266 citations
Involvement of NF‐κB in the regulation of cyclooxygenase‐2 protein expression in LPS‐stimulated J774 macrophages
1997 • 266 citations
The Nuclear Receptor for Melatonin Represses 5-Lipoxygenase Gene Expression in Human B Lymphocytes
1995 • 266 citations
THE ROLE OF ANTI-INFLAMMATORY DRUGS IN THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
1996 • 256 citations
Molecular and Cellular Characterization of the Membrane Attack Complex, C5b-9, in Alzheimer’s Disease
1997 • 254 citations
Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging
1998 • 246 citations
Oxygenation of biological membranes by the pure reticulocyte lipoxygenase.
1990 • 244 citations
Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease
1999 • 243 citations
Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs
1999 • 237 citations
Increased Cerebral Glucose‐6‐Phosphate Dehydrogenase Activity in Alzheimer's Disease May Reflect Oxidative Stress
1986 • 226 citations
Leukotriene B4
1998 • 208 citations
Increased Expression of Cyclooxygenases and Peroxisome Proliferator-Activated Receptor-γ in Alzheimer's Disease Brains
1999 • 205 citations
Complement Biosynthesis in the Central Nervous System
1995 • 199 citations
Cyclo-Oxygenase Isoenzymes
1997 • 198 citations
Evidence of an oxidative challenge in the Alzheimer's brain
1994 • 194 citations
The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation
1998 • 187 citations
Strong nuclear factor-?B-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic alzheimer's disease superior temporal lobe neocortex
1998 • 181 citations
Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells
1994 • 176 citations
Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.
1994 • 176 citations
Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease
1990 • 174 citations
Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type
1995 • 168 citations
Inhibition of the Expression of Inducible Cyclooxygenase and Proinflammatory Cytokines by Sesquiterpene Lactones in Macrophages Correlates with the Inhibition of MAP Kinases
1996 • 158 citations
Interleukin-1β and Glutamate Activate the NF-κB/Rel Binding Site from the Regulatory Region of the Amyloid Precursor Protein Gene in Primary Neuronal Cultures
1996 • 152 citations
Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
1995 • 150 citations
NSAIDs and incident Alzheimer’s disease. the Rotterdam study
1998 • 149 citations
Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation
1998 • 145 citations
Aspartate residue 7 in amyloid β-protein is critical for classical complement pathway activation: Implications for Alzheimer's disease pathogenesis
1997 • 143 citations
Blood levels of histamine, IL-1β, and TNF-α in patients with mild to moderate alzheimer disease
1996 • 138 citations
Nitric oxide synthase gene expression in cholinergic neurons in the rat brain examined by combined immunocytochemistry and in situ hybridization histochemistry
1994 • 122 citations
Interaction of 5-lipoxygenase with cellular proteins
1999 • 120 citations
Aging‐associated up‐regulation of neuronal 5‐lipoxygenase expression: putative role in neuronal vulnerability
1998 • 118 citations
The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease
1996 • 114 citations
Arachidonate 5‐Lipoxygenase and Its Activating Protein: Prominent Hippocampal Expression and Role in Somatostatin Signaling
1996 • 113 citations
Nonsteroidal Anti-Inflammatory Drug Use and Alzheimer's Disease: A Case-Control Study in Rochester, Minnesota, 1980 Through 1984
1998 • 113 citations
Molecular Indices of Neuronal and Glial Plasticity in the Hippocampal Formation in a Rodent Model of Age-Induced Spatial Learning Impairment
1996 • 105 citations
α2-macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease
1993 • 101 citations
MAP Kinase Pathways as a Route for Regulatory Mechanisms of IL-10 and IL-4 Which Inhibit COX-2 Expression in Human Monocytes
1998 • 101 citations
Prostaglandin E2 Induces Interleukin‐6 Synthesis in Human Astrocytoma Cells
1997 • 98 citations
Indomethacin Reverses the Microglial Response to Amyloid β-Protein
1998 • 94 citations
Selective COX-2 inhibitors: is the water becoming muddy?
1999 • 83 citations
Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family.
1992 • 78 citations
Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain
1995 • 77 citations
Septo-hippocampal cholinergic and neurotrophin markers in age-induced cognitive decline
1998 • 74 citations
Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: Complement activation and therapeutic approaches
1996 • 70 citations
Release of Leukotriene B4 from Sublethally Injured Oligodendrocytes by Terminal Complement Complexes
1987 • 69 citations
Serum α1-antichymotrypsin level as a marker for Alzheimer-type dementia
1995 • 66 citations
Distribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer's disease
1998 • 64 citations
Glucocorticoids Stimulate Inflammatory 5‐Lipoxygenase Gene Expression and Protein Translocation in the Brain
1999 • 64 citations
Cytotoxic effect of HIV-1 coat glycoprotein gp120 on human neuroblastoma CHP100 cells involves activation of the arachidonate cascade
1998 • 59 citations
Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia
1996 • 58 citations
Indicators of glial activation and brain oxidative stress after intraventricular infusion of endotoxin
1998 • 58 citations
Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation
1997 • 58 citations
Cultured Rat Microglia Express C1q and Receptor for C1q: Implications for Amyloid Effects on Microglia
1995 • 57 citations
Interleukin‐1β and Tumor Necrosis Factor‐α Induce Expression of α1‐Antichymotrypsin in Human Astrocytoma Cells by Activation of Nuclear Factor‐κB
1996 • 56 citations
Topographic associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus
1997 • 54 citations
A Pilot Study of Prednisone in Alzheimer's Disease
1996 • 48 citations
Increased Hippocampal 5‐Lipoxygenase mRNA Content in Melatonin‐Deficient, Pinealectomized Rats
1997 • 47 citations
IL-1 and anti-inflammatory drugs modulate A β cytotoxicity in PC12 cells
1996 • 44 citations
Circadian expression of pineal 5-lipoxygenase mRNA
1998 • 42 citations
Primary rat astroglial cultures can generate leukotriene B4
1988 • 41 citations
Enhanced Processing of APP Induced by IL-1β Can Be Reduced by Indomethacin and Nordihydroguaiaretic Acid
1995 • 39 citations
Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and β-amyloid
1998 • 33 citations
Inflammatory molecule release by β-amyloid-treated T98G astrocytoma cells: role of prostaglandins and modulation by paracetamol
1998 • 33 citations
Improving the gastrointestinal safety of NSAIDs: the development of misoprostol--from hypothesis to clinical practice.
1998 • 30 citations
Complement activation by cross-linked truncated and chimeric full-length β-amyloid
1997 • 28 citations
Blocking the interleukin-1 receptor inhibits leukotriene B4 and prostaglandin E2 generation in human monocyte cultures
1992 • 28 citations
Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha.
1994 • 27 citations
Primary Cultures of Rat Cerebellar Granule Cells as a Model to Study Neuronal 5‐Lipoxygenase and FLAP Gene Expression
1999 • 26 citations
5-Lipoxygenase gene polymorphism and onset of Alzheimer's disease
2000 • 24 citations
Potential link between interleukin-6 and arachidonic acid metabolism in Alzheimer’s disease
1998 • 24 citations
Down‐regulation of cyclooxygenase‐2 (COX‐2) by interleukin‐1 receptor antagonist in human monocytes
1996 • 23 citations
Arachidonate Metabolites Affect the Secretion of an N-Terminal Fragment of Alzheimer′s Disease Amyloid Precursor Protein
1995 • 22 citations
Induction of manganese superoxide dismutase in BV-2 microglial cells
1997 • 22 citations
Immunostimulation protects microglial cells from nitric oxide-mediated apoptosis
1997 • 21 citations
Nonsteroidal Anti-Inflammatory Drugs as Scaffolds for the Design of 5-Lipoxygenase Inhibitors
1997 • 21 citations
Protection from hypoxic and N-methyl-D-aspartate injury with azelastine, a leukotriene inhibitor
1993 • 21 citations
Age‐dependent change in arachidonic acid metabolic capacity in rat alveolar macrophages
1999 • 18 citations
Microglia and immune activation in Alzheimer's disease.
1993 • 18 citations
Thrombin Stimulates Activation of the Cerebral 5-Lipoxygenase Pathway during Blood-Brain Cell Contact
1996 • 15 citations
Simplified quantitation of gene transcripts in cultured neuroblastoma (SN49) and microglial (BV-2) cells using capillary electrophoresis and laser-induced fluorescence
1996 • 15 citations
THE MIXED LIPOXYGENASE/CYCLOOXYGENASE INHIBITOR SK&F 105809 REDUCES CEREBRAL EDEMA AFTER CLOSED HEAD INJURY IN RAT
1992 • 13 citations
Azelastine protects against CA1 traumatic neuronal injury in the hippocampal slice
1996 • 11 citations
Prostaglandin E2 Induced Polymerization of Human α-1-Antichymotrypsin and Suppressed Its Protease Inhibitory Activity: Implications for Alzheimer's Disease
1998 • 7 citations
Pharmacological Aspects of 5-Lipoxygenase Inhibition
1999 • 2 citations